The Neuradiant 1070 represents the next generation photobiomodulation technology by being the first of its kind to deliver 1070 nanometre infrared light therapy to the brain in combination with the 4-quadrant control that enables clinicians to control the pulse in certain quadrants of the brain.
You can read the results of a clinical trial showing that 1070 nanometre light therapy was successful in improving cognition in patients with dementia here: http://www.aginganddisease.org/EN/10.14336/AD.2021.0229
You can find the study showing how the Neuradiant 1070 improved long COVID brain fog here: https://pubmed.ncbi.nlm.nih.gov/37018063/#:~:text=Each%20device%20for%20PBM%20delivery,treat%20long%20COVID%20brain%20fog.
Read independent reviews from people who have used the Neuradiant 1070 photobiomodulation helmet:
https://au.trustpilot.com/review/neuronic.online
For a five per cent discount off the Neuradiant 1070 photobiomodulation helmet retail price please use this link: https://neuronic.online/discount/SuviM5
Did you know Neuronic devotes 100 per cent of profits to advance the science and development of photobiomodulation through an ongoing program of basic science and applied clinical trials.